Novartis Negotiates Settlement Of Drug Qui Tam Claims, Takes $700M Charge

Mealey's (July 31, 2019, 9:39 AM EDT) -- BASEL, Switzerland — Swiss drug maker Novartis International AG on July 18 said it is in settlement discussions to resolve false claims allegations with regard to three heart drugs and has recorded a provision of $700 million....

Related Sections